Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Emtrix
- Development stage
- Unknown
- Lead developer
- Moberg Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Emtrix is a topical, prescription-free (OTC) treatment designed for nails affected by fungal infection (onychomycosis) or nail psoriasis. Originally developed by Moberg Pharma (formerly Moberg Derma), the product was part of a $155 million divestment to RoundTable Healthcare Partners and Signet Healthcare Partners, who subsequently established Advantice Health to manage the portfolio. Emtrix functions through a physical-chemical mechanism that hydrates and softens the nail plate (keratolytic action) while lowering the local pH to create an environment inhospitable to fungi. It is marketed globally under several brand names, including Nalox and Naloc, and is CE-marked as a medical device in European markets.
- Brand names
- EmtrixNaloxNalocYouDerm EmtrixKerasal Nail
- Other names
- K101K-101K 101Kerasal Fungal Nail Repair Renewal
02
Targets
KRT (Nail keratin)
Beyond the preview
Go deeper on Emtrix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Emtrix.